Published in Biochem J on March 15, 1999
Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions. J Biol Chem (2002) 1.36
Monomeric solution structure of the prototypical 'C' chemokine lymphotactin. Biochemistry (2001) 1.11
Chemokine oligomerization in cell signaling and migration. Prog Mol Biol Transl Sci (2013) 0.83
Exploring platelet chemokine antimicrobial activity: nuclear magnetic resonance backbone dynamics of NAP-2 and TC-1. Antimicrob Agents Chemother (2011) 0.83
Solution structure of CXCL5--a novel chemokine and adipokine implicated in inflammation and obesity. PLoS One (2014) 0.82
Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin. Int J Mol Sci (2017) 0.79
Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™. Biomolecules (2013) 0.75
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry (1992) 4.25
Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04
Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J (1997) 4.04
Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes. J Immunol (1987) 3.78
Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci U S A (1987) 3.74
Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc Natl Acad Sci U S A (1983) 2.92
Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J Mol Biol (1983) 2.75
Complete covalent structure of human beta-thromboglobulin. Biochemistry (1978) 2.64
Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. Biochemistry (1986) 2.61
Three-dimensional structure of interleukin 8 in solution. Biochemistry (1990) 2.40
Neutrophil activation by monomeric interleukin-8. Science (1994) 2.31
The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci (1992) 2.25
A calculation strategy for the structure determination of symmetric dimers by 1H NMR. Proteins (1993) 2.16
Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med (1989) 1.98
Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci U S A (1991) 1.92
Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem (1991) 1.83
The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. J Biol Chem (1989) 1.71
Three-dimensional structure of proteins determined by molecular dynamics with interproton distance restraints: application to crambin. Proc Natl Acad Sci U S A (1986) 1.52
High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A (1992) 1.45
Heteronuclear three-dimensional NMR spectroscopy of isotopically labelled biological macromolecules. Q Rev Biophys (1990) 1.44
Complete resonance assignment for the polypeptide backbone of interleukin 1 beta using three-dimensional heteronuclear NMR spectroscopy. Biochemistry (1990) 1.40
Crystal structure of recombinant human platelet factor 4. Biochemistry (1994) 1.25
Application of molecular dynamics with interproton distance restraints to three-dimensional protein structure determination. A model study of crambin. J Mol Biol (1986) 1.24
Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy. Biochemistry (1989) 1.15
The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution. J Biol Chem (1995) 1.11
Identification and localization of bound internal water in the solution structure of interleukin 1 beta by heteronuclear three-dimensional 1H rotating-frame Overhauser 15N-1H multiple quantum coherence NMR spectroscopy. Biochemistry (1990) 1.09
NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer. Biochemistry (1995) 1.04
The solution structure of melanoma growth stimulating activity. J Mol Biol (1994) 1.02
Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation. J Biol Chem (1997) 0.99
Subunit association and structural analysis of platelet basic protein and related proteins investigated by 1H NMR spectroscopy and circular dichroism. J Biol Chem (1994) 0.96
Synthetic peptides probe folding initiation sites in platelet factor-4: stable chain reversal found within the hydrophobic sequence LIATLKNGRKISL. Biochemistry (1994) 0.95
Neutrophil activating peptide-2 binds with two affinities to receptor(s) on human neutrophils. Biochem Biophys Res Commun (1991) 0.83
Low-affinity platelet factor 4 1H NMR derived aggregate equilibria indicate a physiologic preference for monomers over dimers and tetramers. Biochemistry (1991) 0.82
Secondary structure of neutrophil-activating peptide-2 determined by 1H-nuclear magnetic resonance spectroscopy. Biochem J (1994) 0.82
Effect of low molecular weight aliphatic alcohols and related compounds on platelet factor 4 subunit association. J Biol Chem (1993) 0.79
Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein. Proc Soc Exp Biol Med (1992) 0.79
Expression and purification of active recombinant platelet factor 4 from a cleavable fusion protein. Protein Expr Purif (1992) 0.78
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res (1991) 1.96
Anginex, a designed peptide that inhibits angiogenesis. Biochem J (2001) 1.27
Tri- and diglycine backbone rotational dynamics investigated by 13C NMR multiplet relaxation and molecular dynamics simulations. Biochemistry (1993) 1.25
Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest (1995) 1.19
A retrospective study of advancement genioplasty. Oral Surg Oral Med Oral Pathol (1989) 1.11
A pulsed-field gradient NMR study of bovine pancreatic trypsin inhibitor self-association. Biochemistry (1997) 1.11
Eosinophil peroxidase oxidation of thiocyanate. Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system. J Biol Chem (2001) 1.08
Epidermal growth factor from the mouse. Physical evidence for a tiered beta-sheet domain: two-dimensional NMR correlated spectroscopy and nuclear Overhauser experiments on backbone amide protons. Biochemistry (1985) 1.06
Solution structure of component B from methane monooxygenase derived through heteronuclear NMR and molecular modeling. Biochemistry (1999) 1.06
Assignments of 31P NMR resonances in oligodeoxyribonucleotides: origin of sequence-specific variations in the deoxyribose phosphate backbone conformation and the 31P chemical shifts of double-helical nucleic acids. Biochemistry (1988) 1.04
NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer. Biochemistry (1995) 1.04
Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia. J Biol Chem (1999) 1.03
Structure and dynamics of peptide-amphiphiles incorporating triple-helical proteinlike molecular architecture. Biochemistry (1999) 1.01
NMR structure of a de novo designed, peptide 33mer with two distinct, compact beta-sheet folds. Biochemistry (1997) 1.01
Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding. Biochem J (1995) 1.00
Helix-loop-helix motif in HIV-1 Rev. Biochemistry (1994) 1.00
13C nuclear magnetic resonance relaxation-derived psi, phi bond rotational energy barriers and rotational restrictions for glycine 13C alpha-methylenes in a GXX-repeat hexadecapeptide. Biochemistry (1993) 1.00
Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int J Cancer (1999) 1.00
Epidermal growth factor from the mouse. Structural characterization by proton nuclear magnetic resonance and nuclear overhauser experiments at 500 MHz. Biochemistry (1984) 0.97
Characterization and modification of a monomeric mutant of the lactose repressor protein. Biochemistry (1986) 0.97
Subunit association and structural analysis of platelet basic protein and related proteins investigated by 1H NMR spectroscopy and circular dichroism. J Biol Chem (1994) 0.96
Spiny keratoderma of the palms and soles. J Am Acad Dermatol (1992) 0.96
Allosteric regulation of inducer and operator binding to the lactose repressor. Biochemistry (1986) 0.95
Dissociation of the lactose repressor protein tetramer using high hydrostatic pressure. Biochemistry (1986) 0.95
Synthetic peptides probe folding initiation sites in platelet factor-4: stable chain reversal found within the hydrophobic sequence LIATLKNGRKISL. Biochemistry (1994) 0.95
Sequence-dependent variations in the 31P NMR spectra and backbone torsional angles of wild-type and mutant Lac operator fragments. Biochemistry (1989) 0.95
Residues in Methylosinus trichosporium OB3b methane monooxygenase component B involved in molecular interactions with reduced- and oxidized-hydroxylase component: a role for the N-terminus. Biochemistry (2001) 0.94
Structural dynamics of human deoxyhemoglobin and hemochrome investigated by nuclear gamma resonance absorption (Mössbauer) spectroscopy. Proc Natl Acad Sci U S A (1983) 0.94
13C-NMR relation study of heparin-disaccharide interactions with tripeptides GRG and GKG. Biochem J (1996) 0.94
Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood (2000) 0.93
NMR solution conformation of heparin-derived hexasaccharide. Biochem J (1997) 0.93
Acyl carrier protein from Escherichia coli. Structural characterization of short-chain acylated acyl carrier proteins by NMR. Biochemistry (1985) 0.91
Backbone and side-chain dynamics of residues in a partially folded beta-sheet peptide from platelet factor-4. Protein Sci (1997) 0.91
Cold-induced changes in thyroid function in a poikilothermic mammal, the naked mole-rat. Am J Physiol Regul Integr Comp Physiol (2001) 0.90
Proton NMR and photochemically induced dynamic nuclear polarization studies of peptide fragments obtained by controlled proteolysis of mouse epidermal growth factor. J Biol Chem (1986) 0.90
Structural features of fibronectin synthetic peptide FN-C/H II, responsible for cell adhesion, neurite extension, and heparan sulfate binding. J Biol Chem (1993) 0.90
Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice. Eur J Cancer (2004) 0.90
Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivo. J Am Acad Dermatol (1986) 0.90
Conformational exchange on the microsecond time scale in alpha-helix and beta-hairpin peptides measured by 13C NMR transverse relaxation. Biochemistry (2001) 0.90
NMR solution conformation of heparin-derived tetrasaccharide. Biochem J (1996) 0.89
Two-dimensional 1H and 31P NMR spectra and restrained molecular dynamics structure of an extrahelical adenosine tridecamer oligodeoxyribonucleotide duplex. Biochemistry (1989) 0.89
A simple approach to analyzing protein side-chain dynamics from 13C NMR relaxation data. J Magn Reson (1998) 0.87
Motional dynamics of residues in a beta-hairpin peptide measured by 13C-NMR relaxation. Protein Sci (1998) 0.87
Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Surgery (1995) 0.87
13C multiplet nuclear magnetic resonance relaxation-derived ring puckering and backbone dynamics in proline-containing glycine-based peptides. Biophys J (1995) 0.87
Direct binding of ethanol to bovine serum albumin: a fluorescent and 13C NMR multiplet relaxation study. Biochemistry (1996) 0.86
Human platelet factor 4 subunit association/dissociation thermodynamics and kinetics. Biochemistry (1991) 0.86
B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides. Biochim Biophys Acta (1995) 0.85
Angiostatic proteins and peptides. Crit Rev Eukaryot Gene Expr (2001) 0.85
Effect of temperature on functional properties of carp hemoglobin. J Mol Biol (1980) 0.82
Secondary structure of neutrophil-activating peptide-2 determined by 1H-nuclear magnetic resonance spectroscopy. Biochem J (1994) 0.82
Lysine side-chain dynamics derived from 13C-multiplet NMR relaxation studies on di- and tripeptides. J Biomol NMR (1995) 0.81
Xenopus transcription factor IIIA binds to the flanking regions of the 5 S RNA gene intragenic control region in a unique and highly ordered state. J Biol Chem (1988) 0.81
Acyl carrier protein from Escherichia coli I. Aspects of the solution structure as evidenced by proton nuclear Overhauser experiments at 500 MHz. Biochemistry (1983) 0.81
Rhenium-labeled somatostatin analog RC-160. 1H NMR and computer modeling conformational analysis. J Biol Chem (1994) 0.81
Photo-CIDNP nuclear magnetic resonance as a probe for conformational changes in epidermal growth factor. Biochim Biophys Acta (1986) 0.80
Discovery of the first non-peptide antagonist of the motilin receptor. Drug Des Discov (2001) 0.80
Structural characterization and exposure of aromatic residues in epidermal growth factor from the rat. Biochem J (1986) 0.80
Folding of beta pep-4 beta-sheet sandwich dimers and tetramers is influenced by aliphatic hydrophobic residues at the intersubunit interface. Biochem J (2001) 0.80
Divalent cation binding to reduced and octanoyl acyl-carrier protein. Eur J Biochem (1990) 0.80
Specific binding of ethanol to cholesterol in organic solvents. Biophys J (2000) 0.79
Effect of low molecular weight aliphatic alcohols and related compounds on platelet factor 4 subunit association. J Biol Chem (1993) 0.79
Improved measurement of (15)N-[(1)H] NOEs in the presence of H(N)-water proton chemical exchange. J Magn Reson (2001) 0.79
Multiple native-like conformations trapped via self-association-induced hydrophobic collapse of the 33-residue beta-sheet domain from platelet factor 4. Biochem J (1995) 0.79
1H NMR and CD secondary structure analysis of cell adhesion promoting peptide F-9 from laminin. J Biol Chem (1991) 0.79
Carp hemoglobin. I. Precise oxygen equilibrium and analysis according to the models of Adair and of Monod, Wyman, and Changeux. J Biol Chem (1980) 0.79
Circular dichroism and spin-label studies of carp hemoglobin. J Mol Biol (1980) 0.78
A new approach to visualizing spectral density functions and deriving motional correlation time distributions: applications to an alpha-helix-forming peptide and to a well-folded protein. J Magn Reson (2001) 0.78
Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation. Thromb Haemost (1990) 0.78
Design of a potent novel endotoxin antagonist. Surgery (1997) 0.77
Effect of pH on the conformation and backbone dynamics of a 27-residue peptide in trifluoroethanol. An NMR and CD Study. J Biol Chem (1995) 0.77
Carp hemoglobin. II. The alkaline Bohr effect. J Biol Chem (1980) 0.77
Internal motional amplitudes and correlated bond rotations in an alpha-helical peptide derived from 13C and 15N NMR relaxation. Protein Sci (2000) 0.77
Alopecia areata has low plasma levels of the vasodilator/immunomodulator calcitonin gene-related peptide. Arch Dermatol (1998) 0.77
pH sensitivity of epidermal growth factor receptor complexes. J Cell Biochem (1993) 0.76
Formation of mixed disulfide adducts at cysteine-281 of the lactose repressor protein affects operator and inducer binding parameters. Biochemistry (1986) 0.76
Interactions of integrin GPIIb/IIIa-derived peptides with fibrinogen investigated by NMR spectroscopy. Biochem J (1996) 0.75
Carp hemoglobin. V. Effects of pH and P6-inositol on autooxidation. Biochim Biophys Acta (1979) 0.75
Effects of molecular association on structure and dynamics of a collagenous peptide. Biopolymers (1993) 0.75
Design and evaluation of nonpeptide fibrinogen gamma-chain based GPIIb/IIIa antagonists. J Med Chem (1995) 0.75
Identification of human hookworm in failed-treatment cases using Chinese hamsters (Cricetulus griseus) and scanning electron microscopy. J Helminthol (1991) 0.75
Carp hemoglobin. Functional analysis and thermodynamics of precise oxygen equilibria according to the simple sequential model of Koshland, Némethy and Filmer. J Mol Biol (1981) 0.75
Quarternary structure amplification of protein folding differences observed in 'native' platelet factor-4. FEBS Lett (1995) 0.75
Ionization and solubilization of 4 alkyl benzoic acids and 4 alkyl anilines in sodium taurodeoxycholate solutions. Pharm Res (1997) 0.75
Characterization of human immunodeficiency virus-1 (HIV-1) rev by (time-resolved) fluorescence spectroscopy. J Fluoresc (1994) 0.75
Alcohol-induced protein folding transitions in platelet factor 4: the O-state. Biochemistry (1993) 0.75
Angiogenesis, a target for tumor therapy. J Lab Clin Med (1998) 0.75
Stability of the mandible after advancement and use of dental plus skeletal maxillomandibular fixation: an experimental investigation in Macaca mulatta. J Oral Maxillofac Surg (1987) 0.75
Necrotic encephalitis as a manifestation of acute sarcocystosis in cattle. J S Afr Vet Assoc (1994) 0.75
"Cocktail"-coronary care. N Engl J Med (1984) 0.75
Assembly of Xenopus transcription factor III A-5S RNA complex. Biochemistry (1990) 0.75